Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $8.3591 per ML under NDC 62332059810. Its NADAC has been published 138 times since Jan 3, 2024.
FDA first approved this application on Apr 5, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
15 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332059810
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Generic (ANDA)
FDA Application
ANDA214588FDA Approved
4/5/2023
TE Code
AT
On Market Since
4/5/2023
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 138 times since Jan 3, 2024, and over the history we have for it it has declined 56.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3591 per ML |
|---|---|
| All-time high | $19.3224 (Jan 10, 2024) |
| All-time low | $8.3145 (Jul 22, 2026) |
| 52-week high | $16.1322 |
| 52-week low | $8.3145 |
| Median price | $16.2138 |
| Average price | $15.2721 |
| Largest weekly change | -17.7% (May 20, 2026) |
| Weeks tracked | 138 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $8.3591 per ML (NDC 62332059810), effective Aug 19, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 56.7%. It has been tracked across 138 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Jan 3, 2024, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.3145 (Jul 22, 2026) to a high of $19.3224 (Jan 10, 2024), with a median of $16.2138 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BEPOTASTINE 1.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 62332059810) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.